| 17.49 Delayed Data As of 3:58pm ET |  +0.095 / +0.55%Today’s Change | 15.50 Today|||52-Week Range 21.94 | +3.95% Year-to-Date |
| Karyopharm Signs $150M Royalty Agreement to Support Xpovio Sep 17 / Zacks.com - Paid Partner Content |
| Previous close | 17.39 |
| Today’s open | 17.29 |
| Day’s range | 17.29 - 17.49 |
| Volume | 1,166,605 |
| Average volume (3 months) | 1,512,115 |
| Market cap | $54.2B |
| Earnings growth (last year) | -52.61% |
| Earnings growth (this year) | -210.86% |
| Earnings growth (next 5 years) | +16.80% |
| Revenue growth (last year) | +18.39% |
| P/E ratio | 33.3 |
| Price/Sales | 2.08 |
| Price/Book | 1.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| AGNAllergan | +0.44 | +0.26% |
| ---- | ||
| ZTSZoetis Inc | -0.56 | -0.45% |
| VRTXVertex Pharmaceutica... | -2.32 | -1.30% |
| Next reporting date | October 30, 2019 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $18.9B |
| Annual profit (last year) | $984.1M |
| Net profit margin | 5.20% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
President, CEO & Representative Director Christophe Weber |
Chief Financial Officer Costa Saroukos |
Corporate headquarters Osaka, Osaka |
